HomeAI · summaries
Storia in 4 fonti
As China biotech crackdown calls reverberate in Washington, the pushback gets louder, too
Two federal lawmakers have introduced a bill seeking to apply the review requi | Two federal lawmakers have introduced a bill seeking to apply the review requirements of the Comprehensive Outbound Investment National Security (COINS) Act to investments in Chinese biotechnology.
Confronto fonti
4 prospettive sulla stessa storiaTimeline cronologica
- ·
endpoints.news
Exclusive: Bipartisan group of lawmakers unveil new bill to restrict China biotech
Bipartisan Michigan lawmakers unveil a bill subjecting US-China biotech deals to outbound investment screening, citing national security risks.
- ·
biopharmadive.com
House bill aims to crack down on China biotech deals
A proposal to add biotechnology to the COINS Act follows two big deals involving Pfizer and Bristol Myers, and comes amid U.S. fears that China’s drugmaking progress may threaten…
- ·
pharmaceutical-technology.com
US lawmakers reveal policy to curb collaboration with Chinese biotech - Pharmaceutical Technology
If enacted, BINSA would give lawmakers the right to monitor and restrict American companies from signing biotech and pharma-focused deals with Chinese entities.
- ·
fiercebiotech.com
As China biotech crackdown calls reverberate in Washington, the pushback gets louder, too
Two federal lawmakers have introduced a bill seeking to apply the review requi | Two federal lawmakers have introduced a bill seeking to apply the review requirements of the…
- ·
In Washington, biotech's China hawks are winning the conversation
PhRMA and BIO mobilize against a wave of anti-China biotech bills in Congress as lawmakers move to curb US dealmaking with China.